MELK and neoplasm: Moreover, the antitumor role of miR-505-3p was also further validated in vivo experiments, in which miR-505-3p mimic treatment substantially suppressed the growth and progression of tumor (Fig. 3P-S), and the MELK expression was significantly downregulated in response to miR-505-3p mimic treatment (Fig. 3T).